Suppliers / ESJAY Pharma

ESJAY Pharma

India 176 employees 2 duplicate records merged Updated 9 July 2026

ESJAY Pharma is a finished-dose manufacturer based in India. It appears in 5 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Its GMP standing is certified by EMA. Customs aggregates show $6.9M of exports covering 121 molecules to 1 destination in 2025.

0
active US DMFs
0
valid CEPs
3
registered plants 2 with an FDA FEI number
5
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
2 of 2 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Kancheepuram, India 3027393896
Kanchipuram, India Not on file
East Windsor, United States 3012257624

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA 5 None
EMA None 1

Scale

Year Revenue Exports Destinations
2025 Not reported $6.9M 1
2024 Not reported $204K 1

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. ESJAY Pharma comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts